Aaron Abrams, MD discusses the efforts that have led to, and continue to evolve, the understanding that earlier, higher efficacy treatments improve outcomes for patients with pediatric-onset demyelinating diseases.

For information about claiming CE credits, go to clevelandclinic.org/neuropodcast and click on the episode.